Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Novolog (Pharm-Up 1966) Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	782	925	726	1,409	1,504	1,423
Market Cap Growth	27.45%	27.45%	-48.50%	-6.30%	5.66%	81.80%
Enterprise Value	747	904	674	1,470	1,449	1,385
Last Close Price	1.53	1.81	1.35	2.60	2.72	2.75
PE Ratio	19.88	23.39	-	29.66	35.53	35.52
Forward PE	-	14.02	14.02	14.02	14.02	14.02
PS Ratio	0.39	0.46	0.44	0.93	1.20	1.25
PB Ratio	2.05	2.42	1.83	3.03	3.50	4.81
P/TBV Ratio	14.78	17.47	10.37	13.19	9.06	19.23
P/FCF Ratio	5.39	6.37	4.43	16.07	28.51	43.30
P/OCF Ratio	4.93	5.84	3.63	10.62	18.03	24.34
EV/Sales Ratio	0.37	0.45	0.41	0.98	1.15	1.22
EV/EBITDA Ratio	5.77	8.47	5.01	14.40	15.81	17.29
EV/EBIT Ratio	10.33	12.43	12.50	18.90	20.87	24.07
EV/FCF Ratio	5.15	6.23	4.12	16.77	27.46	42.13
Debt / Equity Ratio	0.52	0.52	0.54	0.46	0.39	0.52
Debt / EBITDA Ratio	1.53	1.53	1.36	1.74	1.55	1.62
Debt / FCF Ratio	1.37	1.37	1.31	2.43	3.16	4.69
Asset Turnover	0.69	0.69	0.63	0.64	0.56	0.52
Inventory Turnover	6.53	6.53	6.74	7.07	4.97	4.26
Quick Ratio	0.83	0.83	0.85	0.87	0.92	0.84
Current Ratio	0.96	0.96	0.96	0.98	1.03	0.99
Return on Equity (ROE)	10.54%	10.54%	-9.15%	11.38%	12.35%	14.50%
Return on Assets (ROA)	1.56%	1.56%	1.29%	2.06%	1.94%	1.66%
Return on Capital (ROIC)	7.63%	7.63%	5.24%	7.63%	8.29%	8.25%
Return on Capital Employed (ROCE)	12.60%	12.60%	8.90%	11.40%	11.60%	12.70%
Earnings Yield	5.06%	4.28%	-5.79%	3.37%	2.81%	2.81%
FCF Yield	18.56%	15.69%	22.57%	6.22%	3.51%	2.31%
Dividend Yield	2.57%	2.70%	2.17%	2.53%	3.44%	0.94%
Payout Ratio	101.17%	101.17%	-	67.14%	75.62%	29.95%
Buyback Yield / Dilution	0.04%	0.04%	0.94%	-0.14%	-9.08%	-22.05%
Total Shareholder Return	2.60%	2.74%	3.12%	2.39%	-5.63%	-21.12%

Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.